Literature DB >> 26624615

How to measure the impact of premenstrual symptoms? Development and validation of the German PMS-Impact Questionnaire.

Johanna N Kues1, Carolyn Janda1, Maria Kleinstäuber1, Cornelia Weise1,2.   

Abstract

With 75% of women of reproductive age affected, premenstrual symptoms are very common, ranging from emotional and cognitive to physical symptoms. Premenstrual Syndrome and Premenstrual Dysphoric Disorder can lead to substantial functional interference and psychological distress comparable to that of dysthymic disorders. The assessment of this impact is required as a part of the diagnostic procedure in the DSM-5. In the absence of a specific measure, the authors developed the PMS-Impact Questionnaire. A sample of 101 women reporting severe premenstrual complaints was assessed with the twenty-two items in the questionnaire during their premenstrual phase in an ongoing intervention study at the Philipps-University Marburg from August 2013 until January 2015. An exploratory factor analysis revealed a two-factor solution (labeled Psychological Impact and Functional Impact) with 18 items. A Cronbach's alpha of 0.90 for Psychological Impact and of 0.90 for Functional Impact indicated good reliability. Convergent construct validity was demonstrated by moderate to high correlations with the Pain Disability Index. Low correlations with the Big Five Inventory-10 indicated good divergent validity. The PMS-Impact Questionnaire was found to be a valid, reliable, and an economic measure to assess the impact of premenstrual symptoms. In future research, cross validations and confirmatory factor analyses should be conducted.

Entities:  

Keywords:  Disability; Premenstrual Dysphoric Disorder (PMDD); Premenstrual Syndrome (PMS); distress; interference; menstruation; psychometric properties

Mesh:

Year:  2015        PMID: 26624615     DOI: 10.1080/03630242.2015.1118734

Source DB:  PubMed          Journal:  Women Health        ISSN: 0363-0242


  5 in total

1.  Lowered Plasma Steady-State Levels of Progesterone Combined With Declining Progesterone Levels During the Luteal Phase Predict Peri-Menstrual Syndrome and Its Major Subdomains.

Authors:  Chutima Roomruangwong; André F Carvalho; Frank Comhaire; Michael Maes
Journal:  Front Psychol       Date:  2019-10-30

2.  Open-label placebo treatment of women with premenstrual syndrome: study protocol of a randomised controlled trial.

Authors:  Antje Frey Nascimento; Jens Gaab; Irving Kirsch; Joe Kossowsky; Andrea Meyer; Cosima Locher
Journal:  BMJ Open       Date:  2020-02-17       Impact factor: 2.692

3.  Trends in Research Related to Premenstrual Syndrome and Premenstrual Dysphoric Disorder From 1945 to 2018: A Bibliometric Analysis.

Authors:  Mingzhou Gao; Dongmei Gao; Hui Sun; Xunshu Cheng; Li An; Mingqi Qiao
Journal:  Front Public Health       Date:  2021-04-21

4.  The effect of a social network-based cognitive behavioral therapy intervention on the severity of premenstrual syndrome symptoms: a protocol of a randomized clinical trial study.

Authors:  Zainab Alimoradi; Somayeh Rajabalipour; Khaled Rahmani; Amir H Pakpour
Journal:  Trials       Date:  2022-04-23       Impact factor: 2.728

5.  Development of an Assessment Tool of Menstrual-Cycle-Related Signs and Symptoms Based on Thai Traditional Medicine Principles for Evaluation of Women's Health.

Authors:  Kodchanipha Sutthibut; Arunporn Itharat; Phechnoy Singchungchai; Preecha Wanichsetakul; Weerachai Pipatrattanaseree; Buncha Ooraikul; Neal M Davies
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-21       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.